Eliott Jones is CEO and co-founder of Biospectal. He is a Silicon Valley-based startup veteran with a deep history of leading innovation in digital transformation, emerging connected technologies and product user experience.

Prior to founding Biospectal, Eliott led product innovation and user experience design initiatives for leading companies including Yahoo, Landor Associates/Young & Rubicam, Intuit, Logitech and Rambus. In addition to executive level strategy and product mentorship in early-stage startups, he has also served as a counselor for Colgate University’s Thought Into Action Institute and SAP’s SAP.io incubator program.

Eliott holds a BA degree in Visual and Environmental Studies, Magna Cum Laude, from Harvard.

Natalie Meyer manages business partnerships and global health programs at Biospectal. She founded two international education and health non-profits, ROC Inc. (in high school) and Ene Empower, (as an undergrad) which she still leads. Prior to joining Biospectal, Natalie worked for an international development consulting firm and worked at Medtronic Labs in 2019 on a hypertension diabetes program in the informal settlement of Kibera, as an undergraduate intern.

Natalie holds a BA in History and Global Health from Middlebury College.

Prof. Patrick Schoettker is Professor and Head of the department of Anesthesiology at the CHUV University Hospital (Lausanne, Switzerland) and the co-founder of Biospectal. He is the inventor of various airway devices and holds various patents in the field of airway management and wireless monitoring.

He is the founding and acting president of the non-profit “Fondation Latine des Voies Aériennes (www.flava.ch)”, which organizes annual difficult airway courses throughout Switzerland and financially supports airway related research.

Professor Schoettker has authored more than 60 peer-reviewed articles, 25 book chapters and is the editor of the book “Perioperative Hemostasis” published by Springer.

Dr. Fred St. Goar HMS ‘84, Cardiologist, Inventor, & Board Member

Fred St Goar is an HMS grad and a practicing cardiologist. He has had a long career as a serial innovator/entrepreneur, holds numerous patents, and has assisted in starting multiple med-tech companies. Dr. St Goar serves as the vice chairman of the board of the Fogarty Innovation, a Silicon Valley non-profit biotech incubator where he has a mission to support globally impactful projects and women innovators. He teaches, and is an innovation mentor, in the Stanford Biodesign program. He is also an adjunct professor at the Rwanda-based University of Global Health Equity. In 1999, he founded the company Evalve which developed the MitraClip, the leading percutaneous therapy for mitral regurgitation. He serves on Harvard Medical School’s Global Health Advisory Council and the Biospectal Board of Directors.

As the inaugural Executive Director of Harvard Grid, Paul Hayre leads the creation of new programs to accelerate the pace of startup formation at Harvard. Paul oversees a fast-growing initiative comprising educational outreach, innovation development, mentoring programs, alumni engagement, and physical space for emerging ventures. Paul is a transformational leader with a record of turning early- to growth-stage concepts into world-class businesses. He has founded technology and medical device start-ups with two exits; designed and founded high-growth divisions in multi-nationals; and bought and sold lower middle market industrial companies. He most recently focused on medical devices and novel healthcare delivery models, and previously founded or grew businesses in the solar, specialty chemicals, and corporate food solution sectors. Paul spent a decade in technology and strategic advisory firms Accenture, EY-Parthenon, and Eastwing Group. He holds a BS in Electrical Engineering from Cornell University and an MBA from Harvard Business School.